Mucormycosis, a fungus infection caused by Mucorales, has a high mortality rates in those with weakened immune systems and ...

Scientists have identified a new pair of antibodies that could fend off multiple COVID-19 variants. Found in people who successfully recovered from the illness, these antibodies attach to a part ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

The likelihood of severe COVID-19 increases with age upon SARS-CoV ... Functional and structural studies of two potent antibodies isolated from individuals exposed only to ancestral SARS-CoV ...

Shares in Sorrento Therapeutics rose 158% on Friday after it revealed plans to start human trials of an antibody therapy that achieved complete inhibition of the coronavirus in preclinical studies.

Misinformation about vaccines has swirled online since US President Donald Trump appointed Robert F. Kennedy Jr. – who has ...

a novel monoclonal antibody candidate against COVID-19. The clinical trial results highlighted improved efficacy and a favorable safety profile, sparking investor enthusiasm amid market conditions ...

Invivyd plans to share detailed data on pemivibart, VYD2311, and COVID-19 antibody immunobridging in the near term. Our government trade tracker caught Pelosi’s 169% AI winner. Discover how to ...

The health ministry granted fast-track approval for a neutralizing antibody on Sept. 27, making it the second COVID-19 treatment available in Japan for patients with mild symptoms. Sotrovimab was ...

At the fifth anniversary of the COVID-19 pandemic, UPMC and Pitt Student Health Services reveal the lasting changes that the ...

Early administration of high-titre COVID-19 convalescent plasma prevents hospitalisation and death in immunocompromised ...